AKT1 and cancer: Conversely, single depletion of endogenous PHLDA1 or PHLDA2 by their specific siRNAs only slightly enhanced AKT activity in cancer cells (Fig. 9b), whereas their co-depletion resulted in a much greater increase in AKT activity.